Sign in

CIK 0001420720

  • Non-accelerated filer
  • Smaller reporting company
Ticker
IBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
262797813
Phone
+1 302-355-0650
Business address
600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
Former names
iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-02-20 Chang Glenn Director Returned to the company · Stock Option (right to buy) −6,000 36,750
2019-02-20 Chang Glenn Director Grant or award · Stock Option (right to buy) +4,500 36,750
2019-02-20 TERENCE RYAN E Chief Scientific Officer Returned to the company · Stock Option (right to buy) −10,000 22,500
2019-02-20 TERENCE RYAN E Chief Scientific Officer Grant or award · Stock Option (right to buy) +7,500 22,500
2019-02-20 TERENCE RYAN E Chief Scientific Officer Returned to the company · Stock Option (right to buy) −10,000 22,500
2019-02-20 TERENCE RYAN E Chief Scientific Officer Grant or award · Stock Option (right to buy) +7,500 22,500
2019-02-20 TERENCE RYAN E Chief Scientific Officer Returned to the company · Stock Option (right to buy) −10,000 22,500
2019-02-20 TERENCE RYAN E Chief Scientific Officer Grant or award · Stock Option (right to buy) +7,500 22,500
2019-02-20 Mullaney James P. Chief Financial Officer Returned to the company · Stock Option (right to buy) −15,000 11,250
2019-02-20 Mullaney James P. Chief Financial Officer Grant or award · Stock Option (right to buy) +11,250 11,250
2019-01-01 DART KENNETH BRYAN 10% owner Other disposition −1 1
2018-07-12 Eastern Capital LTD 10% owner Purchase +2,200,000 $0.90 $2.0M 8,457,734
2018-06-26 Eastern Capital LTD 10% owner Purchase +1,683,334 $0.90 $1.5M 6,257,734
2018-06-26 Eastern Capital LTD 10% owner Purchase · Series B Preferred Shares +5,785 $1,000.00 $5.8M 5,785
2017-11-30 Eastern Capital LTD 10% owner Purchase +12,000,000 $0.20 $2.4M 45,744,000
2017-05-01 ERWIN ROBERT L President Grant or award · Stock Option (right to buy) +300,000 $0.40 $120K 3,350,000
2017-05-01 Kay Robert Executive Chairman and CEO Grant or award · Stock Option (right to buy) +300,000 $0.40 $120K 4,350,000
2017-05-01 FLUG SEYMOUR Director Grant or award · Stock Option (right to buy) +60,000 $0.40 $24K 340,000
2017-05-01 Elliott Arthur Y Director Grant or award · Stock Option (right to buy) +60,000 $0.40 $24K 460,000
2017-05-01 RUSSELL PHILIP K. Director Grant or award · Stock Option (right to buy) +60,000 $0.40 $24K 460,000

Page 15 of 22 · 423 trades